The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups.
Open accessAbstract
PURPOSE: To develop a statistical model that predicts the histology (necrosis, mature teratoma, or cancer) after chemotherapy for metastatic nonseminomatous germ cell tumor (NSGCT). PATIENTS AND METHODS: An international data set was collected comprising individual patient data from six study groups. Logistic regression analysis was used to estimate the probability of necrosis and the ratio of cancer and mature teratoma. RESULTS: Of 556 patients, 250 (45%) had necrosis at resection, 236 (42%) had mature teratoma, and 70 (13%) had cancer. Predictors of necrosis were the absence of teratoma elements in the primary tumor, prechemotherapy normal alfa-fetoprotein (AFP), normal human chorionic gonadotropin (HCG), and elevated lactate dehydrogenase (LDH) levels, a small prechemotherapy or postchemotherapy mass, and a large shrinkage of the mass during chemotherapy. Multivariate combination of predictors yielded reliable models (goodness-of-fit tests, P > .20), which discriminated necrosis well from other histologies (area under the receiver operating characteristic (ROC) curve, .84), but which discriminated cancer only reasonably from mature teratoma (area, .66). Internal and external validation confirmed these findings. CONCLUSION: The validated models estimate with high accuracy the histology at resection, especially necrosis, based on well-known and readily available predictors. The predicted probabilities may help to choose between immediate resection of a residual mass or follow-up, taking into account the expected benefits and risks of resection, feasibility of frequent follow-up, the financial costs, and the patient's individual preferences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Evaluating the Yield of Medical Tests
Harrell, F. E. (1982) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1982.03320430047030 · Cited by 3,490
Estimating the error rate of a prediction rule: improvement on cross-validation
Efron, B. (1983) · Journal of the American Statistical Association · doi:10.1080/01621459.1983.10477973 · Cited by 2,300
Regression with Missing X 's: A Review
Little, R. J. A. (1992) · Journal of the American Statistical Association · doi:10.1080/01621459.1992.10476282 · Cited by 968
Regression Models in Clinical Studies: Determining Relationships Between Predictors and Response
Harre, F. E., Lee, K. L., & Pollock, B. G. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.15.1198 · Cited by 957
Predictive value of statistical models.
Van Houwelingen, J. C., & Le Cessie, S. (1990) · Statistics in Medicine · doi:10.1002/sim.4780091109 · Cited by 621
Logothetis, C. J., Samuels, M. L., Trindade, A., & Johnson, D. E. (1982) · Cancer · doi:10.1002/1097-0142(19821015)50:8<1629::aid-cncr2820500828>3.0.co;2-1 · Cited by 552
Treatment of testicular cancer: a new and improved model.
Einhorn, L. H. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.11.1777 · Cited by 504
Probabilistic prediction in patient management and clinical trials
Spiegelhalter, D. J. (1986) · Statistics in Medicine · doi:10.1002/sim.4780050506 · Cited by 358
Hepatotoxicity following vincristine therapy
Saghir, N. S. E., & Hawkins, K. A. (1984) · Cancer · doi:10.1002/1097-0142(19841101)54:9<1824::aid-cncr2820540910>3.0.co;2-j · Cited by 51
Cited by
Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures
Steyerberg, E. W., Vickers, A. J., Cook, N. R., Gerds, T., Gonen, M., Obuchowski, N., Pencina, M. J., & Kattan, M. W. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181c30fb2 · Cited by 5,170
Self-citationInternal validation of predictive models
Steyerberg, E. W., Harrell, F. E., Borsboom, G. J. J. M., Eijkemans, M. J. C., Vergouwe, Y., & Habbema, J. D. F. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00341-9 · Cited by 2,746
Self-citationVergouwe, Y., Steyerberg, E. W., Eijkemans, M. J. C., & Habbema, J. D. F. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.06.017 · Cited by 636
Self-citationKrege, S., Beyer, J., Souchon, R., Albers, P., Albrecht, W., Algaba, F., Bamberg, M., Bodrogi, I., Bokemeyer, C., Cavallin-Ståhl, E., et al. (2008) · European Urology · doi:10.1016/j.eururo.2007.12.024 · Cited by 617
Self-citationSteyerberg, E. W., Eijkemans, M. J. C., Harrell, F. E., & Habbema, J. D. F. (2001) · Medical Decision Making · doi:10.1177/0272989x0102100106 · Cited by 550
Self-citation
Metadata
- Authors
- Steyerberg, E. W., Keizer, H. J., Fosså, S. D., Sleijfer, D. T., Toner, G. C., Schraffordt Koops, H., Mulders, P. F., Messemer, J. E., Ney, K., & Donohue, J. P.
- Venue
- Journal of Clinical Oncology
- Published
- 1995-05
- Volume
- 13
- Issue
- 5
- Pages
- 1177-1187
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2124583370
- Cited by
- 254
- References
- 11
- FWCI
- 10.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. https://app.cochat.ai/papers/10.1200/jco.1995.13.5.1177
- The paper
- Steyerberg, E. W., Keizer, H. J., Fosså, S. D., Sleijfer, D. T., Toner, G. C., Schraffordt Koops, H., Mulders, P. F., Messemer, J. E., Ney, K., & Donohue, J. P. (1995). Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. Journal of Clinical Oncology. https://doi.org/10.1200/jco.1995.13.5.1177
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.